Exin Therapeutics develops a discovery platform for genetic therapies targeting dysregulated neural circuits across disorders. Their neurotherapeutics utilize advancements in genetics and technology to create treatments for neurological disorders. The company focuses on gene therapy, nucleotide-based therapeutics, and cell-based therapies to address previously untreatable disease mechanisms.